CAM
DXCM icon

Capstone Asset Management’s DexCom DXCM Stock Holding History

Capstone Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,076
Closed -$213K – 1595
2017
Q1 		$213K Buy
+10,076
New +$197K 0.01% 1504
2016
Q4 		– Sell
-9,356
Closed -$205K – 1626
2016
Q3 		$205K Buy
+9,356
New +$208K 0.01% 1519
2013
Q4 		– Sell
-31,020
Closed -$219K – 1895
2013
Q3 		$219K Buy
+31,020
New +$197K 0.01% 1813

Other funds holding DXCM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capstone Asset Management's DXCM Position: Q2 2017 in Review

Capstone Asset Management sold out of DexCom (DXCM) in Q2 2017, closing a stake of 10,076 shares — an estimated $213K sold.

Capstone Asset Management first reported a position in DXCM in Q3 2013 and held it in 3 quarters. The position peaked at $219K in Q3 2013. 310 funds tracked by Wall St. Rank hold DXCM as of Q2 2017.

  • Capstone Asset Management reported no remaining DexCom position as of Q2 2017 after selling out during the quarter.
  • Capstone Asset Management sold 10,076 DexCom shares in Q2 2017, an estimated $213K.
  • Capstone Asset Management first reported a position in DexCom in Q3 2013 and held it in 3 quarters.
  • Capstone Asset Management's DexCom position peaked at $219K in Q3 2013.
  • 310 funds tracked by Wall St. Rank held DexCom as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.